XML 55 R43.htm IDEA: XBRL DOCUMENT v3.22.1
License and Collaboration Agreements (Details) - USD ($)
 1 Months Ended 3 Months Ended
Sep. 30, 2020
Mar. 31, 2022
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Research and License Agreements          
Revenue from collaboration and license agreements   $ 1,055,441    
Apollomics, Inc.          
Research and License Agreements          
Revenue from collaboration and license agreements     $ 1,100,000    
Up-front payment received         $ 9,000,000.0
Milestones based on achievement of certain clinical and regulatory events         75,000,000.0
Milestone payment upon achievement of specified net sales thresholds for all licensed products         $ 105,000,000.0
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1,000,000.0     $ 1,000,000.0  
Apollomics, Inc. | Maximum          
Research and License Agreements          
Tiered percentage of annual net sales         15.00%